Loss of dysferlin or myoferlin results in differential defects in excitation–contraction coupling in mouse skeletal muscle
Abstract Muscular dystrophies are disorders characterized by progressive muscle loss and weakness that are both genotypically and phenotypically heterogenous. Progression of muscle disease arises from impaired regeneration, plasma membrane instability, defective membrane repair, and calcium mishandl...
Guardado en:
Autores principales: | David Y. Barefield, Jordan J. Sell, Ibrahim Tahtah, Samuel D. Kearns, Elizabeth M. McNally, Alexis R. Demonbreun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ace02e8503f4803979e5eef97f341b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.
por: Eduard Gallardo, et al.
Publicado: (2011) -
Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.
por: Verena Schoewel, et al.
Publicado: (2012) -
Functional equivalence of dihydropyridine receptor a1S and b1a subunits in triggering excitation-contraction coupling in skeletal muscle
por: CORONADO,ROBERTO, et al.
Publicado: (2004) -
Regulation of cardiac excitation-contraction coupling by sorcin, a novel modulator of ryanodine receptors
por: FARRELL,EMILY F, et al.
Publicado: (2004) -
Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart
por: Yankun Lyu, et al.
Publicado: (2021)